China's Investors Pour Into Western Biotech Startups

Fledgling biotech and medical-technology startups in the U.S. and Europe have found a new source of cash to pay for costly research: China’s private-equity and venture-capital investors.

from WSJ.com: US Business https://ift.tt/2JQU4bD
via IFTTT